Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a newly emerged coronavirus that is responsible for the current pandemic of coronavirus disease 2019 (COVID-19), which has resulted in more than 3.7 million infections and 260,000 deaths as of 6 May 2020 1 , 2 . Vaccine and therapeutic...

Full description

Saved in:
Bibliographic Details
Published inNature (London) Vol. 583; no. 7815; pp. 290 - 295
Main Authors Pinto, Dora, Park, Young-Jun, Beltramello, Martina, Walls, Alexandra C., Tortorici, M. Alejandra, Bianchi, Siro, Jaconi, Stefano, Culap, Katja, Zatta, Fabrizia, De Marco, Anna, Peter, Alessia, Guarino, Barbara, Spreafico, Roberto, Cameroni, Elisabetta, Case, James Brett, Chen, Rita E., Havenar-Daughton, Colin, Snell, Gyorgy, Telenti, Amalio, Virgin, Herbert W., Lanzavecchia, Antonio, Diamond, Michael S., Fink, Katja, Veesler, David, Corti, Davide
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 09.07.2020
Nature Publishing Group
Subjects
Online AccessGet full text

Cover

Loading…